The Enterprise Value as of June 2026 (TTM) for ImmunityBio, Inc. (IBRX) is 8.36B

According to ImmunityBio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.36B. This represents a change of 95.47% compared to the average of 4.27B of the last 4 quarters.

ImmunityBio, Inc. (IBRX) Historical Enterprise Value (quarterly & annually)

How has IBRX Enterprise Value performed in the past?

The mean historical Enterprise Value of ImmunityBio, Inc. over the last ten years is 2.37B. The current 8.36B Enterprise Value has changed 35.16% with respect to the historical average. Over the past ten years (40 quarters), IBRX's Enterprise Value was at its highest in in the March 2021 quarter at 9.36B. The Enterprise Value was at its lowest in in the December 2018 quarter at 367.14M.

ImmunityBio, Inc. (IBRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ImmunityBio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ImmunityBio, Inc. (IBRX) Average Enterprise Value

How has IBRX Enterprise Value performed in the past?

The current Enterprise Value of ImmunityBio, Inc. (IBRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ImmunityBio, Inc. (IBRX) Enterprise Value vs. Peers

How is IBRX’s Enterprise Value compared to its peers?

ImmunityBio, Inc.’s Enterprise Value is greater than Arcus Biosciences, Inc. (2.31B), greater than Denali Therapeutics Inc. (3.09B), greater than 89bio, Inc. (2.11B), greater than Cogent Biosciences, Inc. (5.65B), greater than Galapagos N.V. (1.58B), greater than Beam Therapeutics Inc. (2.95B), greater than Recursion Pharmaceuticals, Inc. (826.56M), greater than Liquidia Corporation (6.30B), greater than Agios Pharmaceuticals, Inc. (1.67B), greater than Viridian Therapeutics, Inc. (1.35B),

Build a custom stock screener for ImmunityBio, Inc. (IBRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmunityBio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmunityBio, Inc. (IBRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmunityBio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.